Safety and Efficacy of an Antioxidant-rich Multivitamin Supplement in Cystic Fibrosis

Completed · Phase 1/Phase 2

Conditions studied: Cystic Fibrosis

In brief

The purpose of this study is to test the safety and efficacy of the final commercial formulation of an antioxidant enriched multivitamin supplement in softgel capsule form (AquADEKs) in increasing the plasma levels of certain nutrients and antioxidants in individuals with cystic fibrosis. Hypothesis: An oral antioxidant-rich multivitamin supplement (AquADEKs), which uses a Generally Regarded As Safe (GRAS) molecule to form micelle-like vehicles, will safely increase systemic levels of beta-carotene, coenzyme Q10, and gamma-tocopherol, decrease PIVKA-II levels, while maintaining levels of vitamins A and D in the normal range in persons with CF \> 10 years of age.

Key facts

Study ID
NCT01018303
Run by
University of Colorado, Denver
People needed
17
Starts
2007-08-01
Expected to finish
2009-11-01
Last updated by the study team
2012-10-15

Who can join

Age: 10 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.